-
PLGA-Based Nano-Adjuvant Boosts Mucosal Immunity in Chicks
2026-05-14
This study introduces a PLGA-based nano-adjuvant (PEI-LSP-RA-PLGA) that significantly enhances both mucosal and systemic immune responses against H9N2 avian influenza in chicks. Through targeted intestinal delivery and sustained antigen release, it addresses the limitations of traditional vaccine adjuvants, supporting improved vaccine efficacy.
-
Annexin V-FITC/PI Apoptosis Assay Kit: Protocol and QC Guide
2026-05-13
The Annexin V-FITC/PI Apoptosis Assay Kit (SKU K2003) provides a rapid, fluorescence-based workflow for distinguishing apoptotic stages in mammalian cells. It is best suited for research applications requiring early apoptosis detection or cell death pathway analysis using flow cytometry or fluorescence microscopy. The kit is not intended for diagnostic or clinical use and should not be used outside the recommended cell types and detection platforms.
-
Paroxetine Mesylate: Multi-Target Mechanisms and Oncology Pr
2026-05-13
Explore the advanced pharmacological mechanisms of Paroxetine Mesylate, a selective serotonin reuptake inhibitor, and its emerging role as a multi-target agent in oncology. This article delivers a unique, evidence-based perspective that bridges molecular pharmacology with translational cancer research.
-
Lamotrigine: Advanced Protocols for Epilepsy and Cardiac Res
2026-05-12
Lamotrigine (6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine) from APExBIO unlocks robust, reproducible workflows for studying sodium channel and serotonin signaling in neurological and cardiac models. This guide delivers protocol enhancements, troubleshooting strategies, and practical insights rooted in high-throughput BBB assays and validated reference data.
-
Diethylmaleate in Oxidative Stress and Resistance Research
2026-05-12
Diethylmaleate is a powerful tool for dissecting antioxidant defense mechanisms and modeling resistance to oxidative stress in both cell and organismal assays. Recent studies highlight its precision in glutathione depletion and GST inhibition, enabling breakthroughs in toxicology and pest management research.
-
Digoxin as a Na+/K+ ATPase Pump Inhibitor: Protocols & Innov
2026-05-11
Digoxin stands at the intersection of cardiovascular and virology research, offering potent Na+/K+ ATPase inhibition for both arrhythmia models and cell-type specific viral assays. This article equips scientists with actionable workflows, troubleshooting strategies, and translational insights leveraging APExBIO's high-purity Digoxin.
-
5-HT Reuptake Blockade Triggers Pyroptosis in BRAF V600E Mel
2026-05-11
Li et al. identify paroxetine hydrochloride as an inducer of pyroptosis and anti-tumor immunity in BRAF V600E-mutated melanoma by disrupting histone serotonylation and DNA repair. The study demonstrates the therapeutic potential of repurposing antidepressants for resistant melanoma, with implications for proteostasis and protein extraction workflows.
-
Hydrazide-Based VEGFR-2 Inhibitors: Advances in Antiangiogen
2026-05-10
This study reports the design, synthesis, and evaluation of 53 novel hydrazide-based VEGFR-2 inhibitors, highlighting SA7 as a lead compound with potent antiangiogenic and antiproliferative activity. The research underscores the therapeutic relevance of targeting VEGFR-2 in cancer biology and establishes new chemical tools comparable to established agents such as sorafenib.
-
Fludarabine: DNA Synthesis Inhibitor Workflows for Oncology
2026-05-09
Fludarabine’s precise DNA synthesis inhibition unlocks reproducible cell cycle arrest and apoptosis in advanced leukemia and multiple myeloma research. This guide delivers actionable workflow enhancements, troubleshooting strategies, and translational insights, leveraging APExBIO’s rigorously characterized Fludarabine for next-generation oncology studies.
-
Gamma-linolenic Acid (GLA): Precision Immunomodulation in An
2026-05-08
Explore how gamma-linolenic acid (GLA) advances anti-inflammatory research with precision immunomodulation. This article uncovers unique mechanistic insights and assay strategies, connecting GLA's pharmacology to practical, evidence-based applications.
-
HDAC Inhibition Reverses EBV-Driven Plasticity in NPC Cells
2026-05-08
This study uncovers how EBV-induced dedifferentiation in nasopharyngeal carcinoma (NPC) is mediated by LMP1-driven epigenetic repression of CEBPA. It demonstrates that histone deacetylase (HDAC) inhibition can restore differentiation, offering a mechanistic rationale for differentiation therapy in solid tumors.
-
ERK Inhibition Mitigates Mitochondrial Fragmentation and Aut
2026-05-07
Yuan et al. uncover that ERK inhibition protects SH-SY5Y cells from oxygen-glucose deprivation/reoxygenation injury by downregulating Drp1-mediated mitochondrial fragmentation and autophagy. These findings clarify mechanistic links in cerebral ischemia-reperfusion injury and suggest new intervention strategies.
-
Dabigatran Etexilate: Transforming Oral Anticoagulation in V
2026-05-07
This review details the innovation of dabigatran etexilate as the first oral direct thrombin inhibitor for venous thromboembolism (VTE) and atrial fibrillation (AF). The study highlights its predictable anticoagulant effects, reduced need for monitoring, and clinical impact relative to traditional therapies.
-
Prochlorperazine (SKU A8508): Reliable Assay Solutions in Ca
2026-05-06
This scenario-driven article demonstrates how Prochlorperazine (SKU A8508) from APExBIO delivers reproducible, evidence-based solutions for cell viability, proliferation, and cytotoxicity assays in oncology and antiviral research. We address experimental design, protocol optimization, data interpretation, and vendor selection, providing actionable insights for biomedical scientists aiming for high assay fidelity and translational relevance.
-
Macrophage Polarization via TLR4 Pathway in Colitis-Associat
2026-05-06
Liu et al. demonstrate that Jiedu Xiaozheng Yin (JXY) attenuates colitis-associated colorectal cancer (CAC) progression by promoting macrophage polarization towards the pro-inflammatory M1 phenotype through TLR4 signaling. This mechanistic insight highlights the immunomodulatory potential of TCM compounds in tumor microenvironment regulation and offers a foundation for future chemopreventive strategies.